Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults - ScienceDirect
Boostrix Vaccine (Tdap Vaccine) - Bhole Children's Clinic
Infanrix hexa, INN-Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (
Clinical Review Memo - BOOSTRIX
DPT vaccine - Wikipedia
Primary Study vaccine and number Rue de l'Institut 89 1330 Rixensart, Belgium. GlaxoSmithKline (GSK) Biologicals' combined dip
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine
Vaccination against diphtheria, tetanus, pertussis (whooping cough) and polio (dtp-IPV vaccine)
Main Header
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
Infanrix hexa, INN-Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (
e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
Poliomyelitis
Evaluation of immunogenicity and effectiveness of low dose dTap-IPV vaccine used as booster in 4-8 year old children
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...
Boostrix Full Prescribing Information, Dosage & Side Effects | MIMS Indonesia
Medicines Adverse Reactions Committee
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV): Human Vaccines: Vol 6, No 7
Image of boostrix polio pre-filled inj | MIMS Thailand
